Serine protease 47 activators encompass a group of chemical compounds that, while not directly interacting with serine protease 47, facilitate its functional activity within biological systems. The primary mechanism through which these compounds exert their effect is by inhibiting other proteases that would otherwise compete for the same substrates as serine protease 47 or degrade the substrates before serine protease 47 can act on them. For instance, compounds such as benzamidine and AEBSF function as competitive and irreversible inhibitors, respectively, for other serine proteases. Their presence in the cellular environment leads to an enhanced opportunity for serine protease 47 to interact with and process its natural substrates, as the competitive landscape is modified in favor of serine protease 47. This indirect enhancement of activity ensures that serine protease 47 can perform its catalytic functions more effectively due to the reduced proteolytic pressure from other enzymes.
Further, compounds such as TLCK and TPCK selectively target trypsin-like and chymotrypsin-like proteases, leading to a substrate-rich environment conducive to serine protease 47 action. Similarly, inhibitors like gabexate mesilate and nafamostat mesilate, with their broad-spectrum inhibition profiles, can modulate the proteolytic equilibrium, tipping the balance towardsan unimpeded functionality of serine protease 47. This approach of using protease inhibitors to indirectly augment the activity of serine protease 47 is based on the principle of competitive inhibition, where the presence of these inhibitors in the proteolytic network allows serine protease 47 to have preferential access to its substrates. Substances like camostat mesilate, aprotinin, and leupeptin, although structurally diverse, share the common functional attribute of enhancing the substrate availability for serine protease 47 through the inhibition of other proteolytic enzymes. The specificity of these inhibitors towards other proteases ensures that serine protease 47 remains unimpeded in its catalytic role.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Benzamidine | 618-39-3 | sc-233933 | 10 g | $292.00 | 1 | |
Benzamidine is a reversible inhibitor of trypsin-like serine proteases. Through competitive inhibition, it can lead to the accumulation of natural substrates, which in turn enhance the activity of serine protease 47 by substrate competition. | ||||||
AEBSF hydrochloride | 30827-99-7 | sc-202041 sc-202041A sc-202041B sc-202041C sc-202041D sc-202041E | 50 mg 100 mg 5 g 10 g 25 g 100 g | $65.00 $122.00 $428.00 $851.00 $1873.00 $4994.00 | 33 | |
AEBSF is an irreversible serine protease inhibitor. Its binding to other serine proteases can enhance the specific activity of serine protease 47 by reducing competition for shared substrates. | ||||||
L-Lysine | 56-87-1 | sc-207804 sc-207804A sc-207804B | 25 g 100 g 1 kg | $95.00 $263.00 $529.00 | ||
TLCK selectively inhibits trypsin-like serine proteases. By inhibiting these related enzymes, TLCK can indirectly enhance the activity of serine protease 47 by ensuring more substrates are available for its action. | ||||||
TPCK | 402-71-1 | sc-201297 | 1 g | $182.00 | 2 | |
TPCK is a chymotrypsin-like serine protease inhibitor. It enhances serine protease 47 activity by preventing chymotrypsin-like enzymes from degrading substrates that serine protease 47 can act on. | ||||||
Gabexate mesylate | 56974-61-9 | sc-215066 | 5 mg | $100.00 | ||
Gabexate mesilate is a broad-spectrum serine protease inhibitor with anticoagulant properties. By inhibiting competing proteases, it can enhance the functional availability of serine protease 47. | ||||||
Nafamostat mesylate | 82956-11-4 | sc-201307 sc-201307A | 10 mg 50 mg | $82.00 $306.00 | 4 | |
Nafamostat mesilate is a synthetic serine protease inhibitor that can enhance serine protease 47 activity by preventing the degradation of its potential substrates through inhibition of other proteases. | ||||||
Camostat mesylate | 59721-29-8 | sc-203867 sc-203867A sc-203867B sc-203867C sc-203867D sc-203867E | 10 mg 50 mg 500 mg 1 g 10 g 100 g | $43.00 $183.00 $312.00 $624.00 $2081.00 $4474.00 | 5 | |
Camostat mesilate inhibits various serine proteases, which may lead to an increased substrate availability for serine protease 47, thus enhancing its activity. | ||||||
Aprotinin | 9087-70-1 | sc-3595 sc-3595A sc-3595B | 10 mg 100 mg 1 g | $112.00 $408.00 $3000.00 | 51 | |
Aprotinin is a protease inhibitor that can enhance the activity of serine protease 47 by protecting its substrates from degradation by other proteases. | ||||||
Leupeptin hemisulfate | 103476-89-7 | sc-295358 sc-295358A sc-295358D sc-295358E sc-295358B sc-295358C | 5 mg 25 mg 50 mg 100 mg 500 mg 10 mg | $73.00 $148.00 $316.00 $499.00 $1427.00 $101.00 | 19 | |
Leupeptin is an inhibitor of trypsin-like and cysteine proteases. Inhibition of these proteases can lead to enhanced activity of serine protease 47 due to increased substrate availability. | ||||||
E-64 | 66701-25-5 | sc-201276 sc-201276A sc-201276B | 5 mg 25 mg 250 mg | $281.00 $947.00 $1574.00 | 14 | |
E-64 is an irreversible cysteine protease inhibitor. By inhibiting cysteine proteases, it can indirectly enhance the activity of serine protease 47 by increasing the pool of substrates available for it. | ||||||